Volume 9

  • No. 5 November 2015

    In this issue...

    • Dermatology: Three major indications propel partnering

    • Regulatory red carpet rolls out for antibiotic developers

    • Next-generation antibody platforms take off

  • No. 4 October 2015

    In this issue...

    • Medtech partnering: Megamergers and digital health

    • The realization of precision medicine

    • Demand for cancer technologies drives dealmaking

  • No. 3 September 2015

    In this issue...

    • Neuroscience set for deal spree

    • Evolving approaches in age-related disorders

    • Partnering to manipulate the microbiome

  • No. 2 June 2015

    In this issue...

    • A record year for deals

    • Regenerative medicine on the up

    • Academic-industrial partnerships prosper

    • Antibody deals: an update